Corcept Therapeutics Inc (CORT)
ROA
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 106 140 | 91 386 | 94 616 | 94 500 | 101 418 | 116 870 | 112 733 | 111 844 |
| Aktywa razem | w tys. USD | 621 517 | 594 022 | 524 625 | 617 848 | 583 430 | 533 255 | 496 364 | 468 123 |
| ROA | 17,08% | 15,38% | 18,03% | 15,30% | 17,38% | 21,92% | 22,71% | 23,89% |
2023/Q4 obliczenia
ROA = Zysk netto (ttm) ÷ Aktywa razem
= $106 140K ÷ $621 517K
= 17,08%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROA
Corcept Therapeutics Inc
CORT
17,08%
Amphastar Pharmaceuticals Inc
AMPH
9,09%
Catalyst Pharmaceuticals Inc
CPRX
15,19%
Harmony Biosciences Holdings Inc
HRMY
15,88%
Ironwood Pharmaceuticals Inc
IRWD
-212,76%
Myriad Genetics, Inc.
MYGN
-22,97%
Pacira BioSciences Inc
PCRX
2,66%
Prestige Consumer Healthcare Inc
PBH
-2,42%
Schrodinger Inc
SDGR
5,07%
Supernus Pharmaceuticals Inc
SUPN
0,10%
Xencor Inc
XNCR
-13,23%